Impact of lomitapide and lomitapide/ezetimibe combination therapy on low-density lipoprotein subfractions and risk marker ratios. Issue 1 (July 2015) - Toth, P.P.; Case, D.; Joshi, P.; Jones, S.R.; Martin, S.S.